News from Heart Failure 2025: PRAISE-HFrEF, GLP-1RA in HFrEF

Name: Is GLP-1RA use harmful or safe in patients with HFrEF and obesity?
Uploaded: 2025-05-18T04:00:00+00:00
Duration: 2 min 14 s
Description: ESC Heart Failure 2025 – Although small trials have raised concerns about potential harm from GLP-1RA in patients with HFrEF, large-scale data have been li

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Head-to-head comparison of disease-modifying therapies in ATTR-CM
Head-to-head comparison of disease-modifying therapies in ATTR-CM
ESC Heart Failure 2025
Head-to-head comparison of disease-modifying therapies in ATTR-CM
Vincenzo Castiglione, MD
- Vincenzo Castiglione, MD
Uptake of GDMT in HFrEF: from prescriptions to patient adherence and persistence
Uptake of GDMT in HFrEF: from prescriptions to patient adherence and persistence
ESC Heart Failure 2025
Uptake of GDMT in HFrEF: from prescriptions to patient adherence and persistence
Felix Lindberg, MD, PhD
- Felix Lindberg, MD, PhD
Acoramidis lowers AF burden in ATTR-CM
Acoramidis lowers AF burden in ATTR-CM
ESC Heart Failure 2025
Acoramidis lowers AF burden in ATTR-CM
Kevin Alexander, MD
- Kevin Alexander, MD
Effects of a switch in fluid management in patients with chronic HF
Effects of a switch in fluid management in patients with chronic HF
ESC Heart Failure 2025
Effects of a switch in fluid management in patients with chronic HF
Job Herrmann, MD
- Job Herrmann, MD

Is GLP-1RA use harmful or safe in patients with HFrEF and obesity?

Recommended

Title